Biotechnology

New patent for the drug Optinose Us XHANCE – DrugPatentWatch

[ad_1]

Copyright © DrugPatentWatch. Originally published in New patents for the drug Optinose Us XHANCE

Annual Drug Patent Expiration for XHANCE
Annual Drug Patent Expiration for XHANCE

Xhance is a drug marketed by Optinose Us Inc and included in one NDA. It is available from a single supplier. There are thirteen patents protecting this drug.

XHANCE drug price trends.

This drug has two hundred and fifty-three patent family members in twenty-nine countries.

The generic ingredient in XHANCE is fluticasone propionate. One registered supplier for this compound. Additional details are available on the fluticasone propionate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published in New patents for the drug Optinose Us XHANCE

[ad_2]

Source link

Related Articles

Back to top button